IS3717A7 - Aðferð til að framleiða uppskriftir að geislavirkum lyfjablöndum - Google Patents

Aðferð til að framleiða uppskriftir að geislavirkum lyfjablöndum

Info

Publication number
IS3717A7
IS3717A7 IS3717A IS3717A IS3717A7 IS 3717 A7 IS3717 A7 IS 3717A7 IS 3717 A IS3717 A IS 3717A IS 3717 A IS3717 A IS 3717A IS 3717 A7 IS3717 A7 IS 3717A7
Authority
IS
Iceland
Prior art keywords
ligand
frozen
radiopharmaceutical
divalent metal
radiopharmaceutical preparations
Prior art date
Application number
IS3717A
Other languages
English (en)
Other versions
IS1704B (is
Inventor
Simon Jamie
R. Garlich Josheph
Keith Frank R.
Mcmillan Kenneth
Original Assignee
The Dow Chemical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Dow Chemical Company filed Critical The Dow Chemical Company
Publication of IS3717A7 publication Critical patent/IS3717A7/is
Publication of IS1704B publication Critical patent/IS1704B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
IS3717A 1990-06-18 1991-06-14 Aðferð til að framleiða uppskriftir að geislavirkum lyfjablöndum IS1704B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53887190A 1990-06-18 1990-06-18

Publications (2)

Publication Number Publication Date
IS3717A7 true IS3717A7 (is) 1991-12-19
IS1704B IS1704B (is) 1998-12-10

Family

ID=24148781

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3717A IS1704B (is) 1990-06-18 1991-06-14 Aðferð til að framleiða uppskriftir að geislavirkum lyfjablöndum

Country Status (32)

Country Link
US (1) US5762907A (is)
EP (1) EP0462787B1 (is)
JP (2) JP3636728B2 (is)
KR (1) KR100219964B1 (is)
CN (1) CN1033143C (is)
AT (1) ATE123955T1 (is)
AU (2) AU651112B2 (is)
BR (2) BR9102579A (is)
CA (1) CA2044812C (is)
CS (1) CS184291A3 (is)
CY (1) CY1891A (is)
DE (1) DE69110554T2 (is)
DK (1) DK0462787T3 (is)
EG (1) EG19862A (is)
ES (1) ES2073678T3 (is)
FI (1) FI101044B (is)
GR (1) GR3017430T3 (is)
HK (1) HK80496A (is)
HU (1) HU226897B1 (is)
IE (1) IE71023B1 (is)
IL (1) IL98536A (is)
IS (1) IS1704B (is)
MC (1) MC2260A1 (is)
NO (1) NO302510B1 (is)
NZ (1) NZ238547A (is)
PH (1) PH30975A (is)
PL (1) PL165699B1 (is)
PT (1) PT97996B (is)
RU (1) RU2095085C1 (is)
SA (1) SA92120343B1 (is)
SK (1) SK279598B6 (is)
ZA (1) ZA914615B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410043A (en) * 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
US5405601A (en) * 1993-07-02 1995-04-11 Mallinckrodt Medical Inc. Functionalized tripodal ligands for imaging applications
CN1065769C (zh) * 1997-07-03 2001-05-16 中国原子能科学研究院 一种放射性药物制剂的制备方法
CN1092962C (zh) * 1998-01-26 2002-10-23 贾伟 一种减轻骨及骨关节疾病疼痛的药物
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
US6567492B2 (en) 2001-06-11 2003-05-20 Eastern Isotopes, Inc. Process and apparatus for production of F-18 fluoride
ES2347535T3 (es) 2002-11-05 2010-11-02 Ion Beam Applications S.A. Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol.
US7018614B2 (en) * 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
MX362001B (es) * 2013-05-13 2019-01-03 Vision Global Holdings Ltd Composición farmacéutica que comprende un agente terapéutico a base de hemoglobina modificada para tratamiento dirigido al cáncer e imagenología diagnóstica.
PT3054996T (pt) 2013-10-07 2023-08-01 Igl Pharma Inc Processo para preparar agentes ósseos terapêuticos de alta pureza
AU2015356971B2 (en) 2014-12-04 2021-09-09 Ge Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
RU2593017C1 (ru) * 2015-04-23 2016-07-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения радиофармацевтического препарата "астат-211"
US10736975B2 (en) 2015-05-21 2020-08-11 Actinium Pharmaceuticals, Inc. Infusion administration of conjugated monoclonal antibodies
CA2987242C (en) 2015-05-25 2023-10-10 Isotherapeutics Group, Llc Dotmp kit formulations for radioisotopes
RU2757258C1 (ru) * 2020-09-28 2021-10-12 федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский ядерный университет "МИФИ" (НИЯУ МИФИ) Способ получения радиофармацевтического препарата с галлием-68 для визуализации метастазов скелета методом пэт

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018883A (en) * 1975-03-10 1977-04-19 Nichols Institute For Endocrinology Thyroxine (T4) radioimmunoassay
US4111656A (en) * 1975-06-26 1978-09-05 Mallinckrodt, Inc. Radioimmunoassay methods for the determination of l-triiodothyronine and thyroxine
US4301140A (en) * 1979-12-14 1981-11-17 G. D. Searle & Co. Radiopharmaceutical method for monitoring kidneys
US4341755A (en) * 1980-07-15 1982-07-27 Immuno Nuclear Corporation Parathyroid radioimmunoassay
US4457602A (en) * 1981-04-20 1984-07-03 Olympus Optical Company Ltd. Multiple light emission control system utilizing electronic flashes
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
ZA852799B (en) * 1984-06-04 1986-12-30 Dow Chemical Co Organic amine phosphonic acid complexes for the treatment of calcific tumors
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4752464A (en) * 1985-06-07 1988-06-21 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
NZ222304A (en) * 1987-05-18 1990-10-26 Dow Chemical Co Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes
AU629171B2 (en) * 1987-06-30 1992-10-01 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents
US4937333A (en) * 1989-08-04 1990-06-26 The Dow Chemical Company Method for purifying aminomethylenephosphonic acids for pharmaceutical use
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes

Also Published As

Publication number Publication date
JP2002114712A (ja) 2002-04-16
NO912345L (no) 1991-12-19
AU665911B2 (en) 1996-01-18
RU2095085C1 (ru) 1997-11-10
DK0462787T3 (da) 1995-10-30
FI101044B (fi) 1998-04-15
IL98536A (en) 1996-10-31
ATE123955T1 (de) 1995-07-15
NO302510B1 (no) 1998-03-16
EP0462787B1 (en) 1995-06-21
BR1101169A (pt) 2000-08-08
CA2044812A1 (en) 1991-12-19
FI912933A (fi) 1991-12-19
PT97996A (pt) 1992-03-31
KR100219964B1 (ko) 1999-09-01
DE69110554D1 (de) 1995-07-27
JP3636728B2 (ja) 2005-04-06
HU912011D0 (en) 1991-12-30
PL165699B1 (pl) 1995-01-31
HU226897B1 (en) 2010-01-28
IE912057A1 (en) 1991-12-18
AU651112B2 (en) 1994-07-14
HUT57994A (en) 1992-01-28
CN1063615A (zh) 1992-08-19
NO912345D0 (no) 1991-06-17
IS1704B (is) 1998-12-10
MC2260A1 (fr) 1993-04-26
EG19862A (en) 1996-06-30
PL290717A1 (en) 1992-02-24
IE71023B1 (en) 1997-01-15
CA2044812C (en) 2002-12-31
SA92120343B1 (ar) 2004-01-25
CY1891A (en) 1996-08-30
JPH04230224A (ja) 1992-08-19
GR3017430T3 (en) 1995-12-31
PH30975A (en) 1997-12-23
CS184291A3 (en) 1992-02-19
NZ238547A (en) 1994-05-26
US5762907A (en) 1998-06-09
EP0462787A1 (en) 1991-12-27
AU7847091A (en) 1991-12-19
KR920000334A (ko) 1992-01-29
PT97996B (pt) 1998-11-30
IL98536A0 (en) 1992-07-15
DE69110554T2 (de) 1995-12-14
SK279598B6 (sk) 1999-01-11
BR9102579A (pt) 1992-01-21
ES2073678T3 (es) 1995-08-16
ZA914615B (en) 1993-02-24
FI912933A0 (fi) 1991-06-17
HK80496A (en) 1996-05-17
AU6455994A (en) 1994-08-04
CN1033143C (zh) 1996-10-30

Similar Documents

Publication Publication Date Title
IS3717A7 (is) Aðferð til að framleiða uppskriftir að geislavirkum lyfjablöndum
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
WO1992000759A3 (en) Stabilized therapeutic radiopharmaceutical complexes
NO953457D0 (no) Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse
EP0325559A3 (en) Process for the preparation of complex compounds
DE58905681D1 (de) Pharmazeutische Präparate zur verbesserten Resorption antibakterieller Verbindungen.
NO924647D0 (no) Krystallinske fumarsyresalter av 9,9-alkylen-3,7-diazabicyklononanforbindelser, og legemidler inneholdende disse
ATE23800T1 (de) Roentgen-sichtbarmachungsmittel.
DK229089D0 (da) Peptid-laegemiddelpraeparater indeholdende alfa-aminoborsyrederivater til indgift via slimhinden
DK156438C (da) Phenylaminoalkylketon-derivater og farmaceutisk praeparat inholdende disse